Kyle Rose
Stock Analyst at Canaccord Genuity
(3.34)
# 739
Out of 4,829 analysts
114
Total ratings
51.65%
Success rate
12.84%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $28.34 | -4.73% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $310.67 | +4.29% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $380.92 | +14.20% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $55.82 | +27.19% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $33.05 | +114.83% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.45 | +52.25% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.87 | +434.76% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $12.21 | +80.18% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $84.67 | +77.16% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $8.62 | +3,032.25% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $18.49 | +46.02% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.08 | +1,288.89% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $11.37 | +31.98% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $178.33 | -31.59% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.13 | +27.80% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.68 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $95.21 | +31.29% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $28.34
Upside: -4.73%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $310.67
Upside: +4.29%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $380.92
Upside: +14.20%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $55.82
Upside: +27.19%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $33.05
Upside: +114.83%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.45
Upside: +52.25%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.87
Upside: +434.76%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $12.21
Upside: +80.18%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $84.67
Upside: +77.16%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $8.62
Upside: +3,032.25%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $18.49
Upside: +46.02%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.08
Upside: +1,288.89%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $11.37
Upside: +31.98%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $178.33
Upside: -31.59%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.13
Upside: +27.80%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.68
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $95.21
Upside: +31.29%